Affordable Access

Prolonged follow-up after initial therapy with 2-chlorodeoxyadenosine in patients with indolent non-Hodgkin lymphoma: results of Cancer and Leukemia Group B Study 9153.

Authors
  • Blum, Kristie A
  • Johnson, Jeffrey L
  • Niedzwiecki, Donna
  • Piro, Lawrence D
  • Saven, Alan
  • Peterson, Bruce A
  • Byrd, John C
  • Cheson, Bruce D
Type
Published Article
Journal
Cancer
Publication Date
Dec 15, 2006
Volume
107
Issue
12
Pages
2817–2825
Identifiers
PMID: 17120198
Source
Medline
License
Unknown

Abstract

2-CdA is an active, well-tolerated therapy for patients with untreated, indolent NHL.

Report this publication

Statistics

Seen <100 times